Get short, timely messages from FDA Drug Information.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @FDA_Drug_Info.

Get updates via SMS by texting follow FDA_Drug_Info to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

FDA_Drug_Info

  1. Reumofan Plus: Recall - Undeclared Drug Ingredient. 1.usa.gov/RmfnPlusRecall.
  2. #Parents should avoid using #benzocaine products to relieve #teething pain for children under 2. go.usa.gov/dY1
  3. FDA warns consumers about counterfeit version of Teva’s Adderall. 1.usa.gov/CtrftAddT
  4. Podcast: FDA advises healthcare providers to visually inspect Hospira Carpuject pre-filled cartridges. bit.ly/CarpujectPT
  5. Registration Open: FDA Small Business Regulatory Education for Industry (REdI) Conference Spring 2012. 1.usa.gov/SmBREdI
  6. FDA advises healthcare providers to visually inspect Hospira Carpuject pre-filled cartridges for overfill 1.usa.gov/CarpujectR
  7. EPA/FDA/NPS/National Council on Skin Cancer Prevention Highlight Sun Safety Tips for 'Don’t Fry Day' 5/25. 1.usa.gov/dfdrqst1
  8. En Espanol: Safety Communication: Safety review of a reported death after first dose of Gilenya (fingolimod). 1.usa.gov/GilenyaS
  9. eDRLS: The NDC Directory will move to weekly updates beginning at the end of May. Visit the NDC Directory at: 1.usa.gov/edrlsrqst2
  10. FDA approves generic versions of blood thinner Plavix. 1.usa.gov/GenClopApp
  11. Public Summary of Drug Safety Oversight Board Meeting, March 15, 2012 available: 1.usa.gov/DSBrqst
  12. En Espanol: Safety Communication: Safety update of Revlimid & risk of developing new types of malignancies. 1.usa.gov/RevlimidUpS
  13. FDA Statement regarding azithromycin (Zithromax) and the risk of cardiovascular death. 1.usa.gov/azithCVT
  14. Drug Safety Podcast: Revised recommendations for cardiovascular monitoring and use of Gilenya. bit.ly/GilUpPT
  15. FDA Voice Blog: Six Month Check-Up: FDA’s Work on Drug Shortages. bit.ly/blogrqst
  16. Safety Communication: Revised recommendations for cardiovascular monitoring and use of MS drug Gilenya. 1.usa.gov/gilenyaT
  17. FDA Safety Communication:Chronic Cerebrospinal Venous Insufficiency Treatment in Multiple Sclerosis Patients. 1.usa.gov/CDRHrqst
  18. Podcast: Safety review update of cancer drug Revlimid and risk of developing new types of malignancies. 1.usa.gov/RevUpPT
  19. Drug Safety Communication: Update of cancer drug Revlimid and risk of developing new types of malignancies. 1.usa.gov/RevDSCT
  20. View Free FDA Webinar: Practical Advice for Preventing Surgical Fires: June 12, 2012 @1-2pm EST. 1.usa.gov/SurgRqst